Research & Educational Use Only. This protocol guide is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before beginning any research protocol.
Experimental Targeted Fat Cell Apoptosis Peptide
Weekly Protocol Guide
Adipotide Protocol Guide
Adipotide (also known as FTPP) is an experimental peptidomimetic that targets prohibitin on the vasculature of white adipose tissue. It induces apoptosis in fat cells by disrupting their blood supply. VERY limited research use - this compound has significant safety considerations and is NOT approved for clinical use.
Protocol Overview
- Compound
- Adipotide (Prohibitin-Targeting Peptidomimetic - VERY LIMITED USE)
- Category
- Experimental Targeted Fat Cell Apoptosis Peptide
- Vial Size
- 1mg (1,000mcg)
- Reconstitution
- 1mL bacteriostatic water (1mg/mL)
- Route
- Subcutaneous injection
- Frequency
- 3 days/week
Reconstitution Instructions
Using 1mL of bacteriostatic water results in a concentration of 1mg/mL. EXPERIMENTAL compound - very limited research use only. Always use sterile techniques.
Materials Needed
- 1mg Adipotide 1mg vial (lyophilized powder)
- 1mL bacteriostatic water (sterile, preserved with 0.9% benzyl alcohol)
- Sterile syringe and needle (18-22 gauge for drawing)
- Alcohol swabs
- Clean workspace
Step-by-Step Process
- Preparation: Allow the Adipotide 1mg vial and bacteriostatic water to reach room temperature. Wipe the rubber stoppers of both vials with an alcohol swab.
- Draw the Water: Using a sterile syringe, draw up exactly 1mL of bacteriostatic water. Expel any air bubbles.
- Inject into Vial: Insert the needle through the rubber stopper at a slight angle, aiming toward the glass wall. Slowly inject the water down the side of the vial to avoid foaming.
- Mix Gently: Remove the needle. Gently swirl or roll the vial between your hands. Do not shake vigorously.
- Check for Clarity: The solution should be clear once fully reconstituted. Do not use if cloudy.
Weekly Dosing Schedule
| Day | Units | Dose | Timing |
|---|---|---|---|
| Monday | 10 | 0.1mg | Morning |
| Wednesday | 10 | 0.1mg | Morning |
| Friday | 10 | 0.1mg | Morning |
Weekly Total: 30 units (0.3mg) • Vial Duration: ~10 doses
Quick Dosing Reference
| Units (Ticks) | Dose (mcg) | Dose (mg) |
|---|---|---|
| 5 | 50 | 0.05mg |
| 10 | 100 | 0.1mg |
| 20 | 200 | 0.2mg |
| 30 | 300 | 0.3mg |
| 50 | 500 | 0.5mg |
Administration Guidelines
- EXPERIMENTAL - for supervised research use only
- Administer subcutaneously at very low doses
- Start at lowest possible dose (0.1mg) and do not exceed without protocol guidance
- Monitor renal function closely - nephrotoxicity has been observed in primate studies
- Rotate injection sites between abdomen, thigh, and upper arm
- Store reconstituted peptide refrigerated at 36-46F (2-8C)
- Use reconstituted solution within 30 days
- Never freeze reconstituted peptides
- Document all administration times and observations meticulously
Storage Requirements
| State | Storage Conditions |
|---|---|
| Lyophilized (powder) | Room temperature or refrigerated, protect from light |
| Reconstituted | Refrigerated 36-46F (2-8C), use within 30 days |